| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/28/2007 | EP1757302A1 Adiponectin expression inducer and utilization of the same |
| 02/28/2007 | EP1757300A1 Agent for removing factor causing circulatory dysfunction |
| 02/28/2007 | EP1757297A1 Composition for inhibiting the onset of arteriosclerosis and inhibition method |
| 02/28/2007 | EP1757291A2 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-YL)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof |
| 02/28/2007 | EP1757282A1 The use of kauranes compounds in the manufacture of medicament |
| 02/28/2007 | EP1756569A1 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis |
| 02/28/2007 | EP1756092A1 Novel inhibitors of rho-kinases |
| 02/28/2007 | EP1756041A2 Polycationic compounds and uses thereof |
| 02/28/2007 | EP1755681A2 Combination of organic compounds |
| 02/28/2007 | EP1755620A2 Sulphated depolymerised exopolysaccharide derivatives, their preparation and uses |
| 02/28/2007 | EP1755604A2 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 02/28/2007 | EP1755594A1 Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor |
| 02/28/2007 | EP1755582A1 Pharmaceutical compositions for the prevention and treatment of atherosclerosis |
| 02/28/2007 | EP1755581A1 Methods and compositions for the treatment of myocardial conditions |
| 02/28/2007 | EP1572179B1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 02/28/2007 | EP1509522B1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 02/28/2007 | EP1507776B1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1392666B1 Biologically active methylene blue derivatives |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 02/28/2007 | EP1368094B1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a|-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1301201B1 Treatment of glycogen storage disease type ii |
| 02/28/2007 | EP1276491B9 Tamandarin and didemnin analogs and methods of making and using them |
| 02/28/2007 | EP1272186B1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 02/28/2007 | EP1233013B1 Novel phenylalanine derivatives |
| 02/28/2007 | EP1096937B9 Sustained release ranolazine formulations |
| 02/28/2007 | EP0758390B1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921886A Methods of modulating cytokine activity, related reagents |
| 02/28/2007 | CN1921871A Physiologically active composition and process for producing the same |
| 02/28/2007 | CN1921855A KV1.5-blocker for the selective increase of atrial contractility and treatment of cardiac insufficiency |
| 02/28/2007 | CN1921853A Preventive or therapeutic agents for severe diabetic retinopathy |
| 02/28/2007 | CN1921843A Retinoic acid-containing remedy for diabetes |
| 02/28/2007 | CN1919848A bilobalide K and complex thereof, preparation method and use for the same |
| 02/28/2007 | CN1919309A Medicine for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919308A Quality controlling means of traditional medicine Injectio |
| 02/28/2007 | CN1919307A Quality controlling means of traditional medicine Injectio |
| 02/28/2007 | CN1919306A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919305A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919304A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919303A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919302A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919301A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919300A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919278A Blood activating oil and its preparation method |
| 02/28/2007 | CN1919272A Traditional Chinese medicine concentrated pill |
| 02/28/2007 | CN1919266A Medicine composition for treating cardiovascular and cerebrovascular diseases, preparation method and use thereof |
| 02/28/2007 | CN1919258A Application of schisandra chinensis in the preparation of medicine for preventing and reducing toxic and side effect of antitumor agent |
| 02/28/2007 | CN1919255A Aim Naoluotong drop pill and its preparation method |
| 02/28/2007 | CN1919253A Cardiac and cerebral vascular disease treating medicinal composition |
| 02/28/2007 | CN1919252A Medicine for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919251A Traditional Chinese medicine composition for treating cardiac vascular disease |
| 02/28/2007 | CN1919250A Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919249A Chinese traditional medicine for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919248A Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919247A Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919246A Traditional Chinese medicine for treating cardiovascular diseases |
| 02/28/2007 | CN1919245A Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 02/28/2007 | CN1919244A Chinese traditional medicine for treating cardiovascular disease |
| 02/28/2007 | CN1919243A Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 02/28/2007 | CN1919242A Traditional Chinese medicine composition for treating cardiac and cerebral vascular disease |
| 02/28/2007 | CN1919241A Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919240A Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
| 02/28/2007 | CN1919239A Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 02/28/2007 | CN1919238A Medicine for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919237A Medicine for treating cardiovascular and cerebrovascular diseases |
| 02/28/2007 | CN1919236A Medicine for treating cardiovascular and cerebrovascular diseases |
| 02/28/2007 | CN1919235A Cardiac and cerebral vascular disease treating pharmaceutical composition |
| 02/28/2007 | CN1919234A Application of pharmaceutical composition in the process of preparing medicine for preventing and treating plateau cardiac muscle hypoxidosis |
| 02/28/2007 | CN1919230A Pharmaceutical composition comprising notoginsen triterpenes and astragalus root extract |
| 02/28/2007 | CN1919224A Method for extracting medicinal ingredient of erigeron breviscapus |
| 02/28/2007 | CN1919223A Medicinal composition of notoginsen triterpenes and notoginsenoside |
| 02/28/2007 | CN1919222A Process for preparing notoginsen triterpenes |
| 02/28/2007 | CN1919219A Refining method of ginko total chromocor and method for preparing ginko damo injection |
| 02/28/2007 | CN1919217A Capsule made of ant extract, spirulina platensis dry powder and chinese caterpillar fungus extract |
| 02/28/2007 | CN1919214A Monascus soft capsule and its preparation method |
| 02/28/2007 | CN1919213A Monascus pellet and its preparing method |
| 02/28/2007 | CN1919207A Gariic and medlar capsule |
| 02/28/2007 | CN1919206A Vitexin injection and oral administration preparation thereof |
| 02/28/2007 | CN1919202A Pharmaceutical composition of pharmacy acceptable salt of carthamus tinctorius yellow colour and ferulaic acid |
| 02/28/2007 | CN1919201A Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 02/28/2007 | CN1919197A Slow release drop pills comprising toraesmide active ingredient and method for preparing same |
| 02/28/2007 | CN1919195A Vinpocetine drop pills and its preparation method |
| 02/28/2007 | CN1301997C Benzosulfones with calcium antagonist activity |
| 02/28/2007 | CN1301988C Method of extracting terpene lactone from folium ginkgo leaves and product |
| 02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301715C Pregnenolone in steroid species and isomeric compound in application of preparing medicaton for treating high blood pressure |
| 02/28/2007 | CN1301712C Indolyl-3-glyoxylic acid derivatives comprising therapeutically valuable properties |
| 02/28/2007 | CN1301710C Therapeutic methods and compositions involving isoflavones |
| 02/28/2007 | CN1301707C Danhong freeze dried powder injection agent and its preparation method |
| 02/27/2007 | US7183436 Substituted 4-aminocyclohexanols |
| 02/27/2007 | US7183379 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/27/2007 | US7183322 Remedy for hypertension |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183311 NF-κB inhibitors |